Abba Medix Group Inc. Announces Warrant Extension

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 01/26/16 -- Abba Medix Group Inc. (the "Company" or "Abba") (CSE: ABA) is pleased to announce that it has received approval from the Canadian Securities Exchange to extend the expiry term of 5,487,723 common share purchase warrants (the "Warrants") issued as a part of its 2015 reverse take-over transaction. This amendment represents the first amendment made to the Warrants.

The original expiry date of the Warrants was March 13, 2016. The new expiry date of the Warrants is March 13, 2018. All other terms and conditions of the Warrants remain unchanged. The Company will deliver a notice reflecting the amended expiry date to the registered holders of the Warrants.

About Abba Medix Group Inc.

Abba Medix Group Inc. (CSE: ABA) is the parent company of Abba Medix Corp.; a company committed to becoming a purveyor of fine medical cannabis in Canada. In compliance with Health Canada's regulations, the Company's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated medical cannabis marketplace. Abba's mission is to find, acquire or create joint venture opportunities in patient focused medical cannabis related companies, products, organizational events, sponsorships, educational training, and research and development within medical cannabis sector. For more information please visit .



Contacts:
Ray Ahmad Rasouli
Chief Executive Officer
Abba Medix Group Inc.
Tel: (905) 492-9420

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 26.01.2016 - 22:39 Uhr
Sprache: Deutsch
News-ID 446684
Anzahl Zeichen: 0

contact information:
Town:

TORONTO, ONTARIO

Kategorie:

Alternative

Diese Pressemitteilung wurde bisher 239 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Abba Medix Group Inc. Announces Warrant Extension"
steht unter der journalistisch-redaktionellen Verantwortung von

Abba Medix Group Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Abba Medix Group Completes $6 Million Financing in Support of Proposed Clinical ...

TORONTO, ONTARIO -- (Marketwired) -- 09/06/16 -- Abba Medix Group Inc. ("Abba" or the "Company") (CSE: ABA) has completed its previously announced offering (the "Offering") pursuant to which it has issued and sold on a ...

Abba Medix Group Engages Mackie Research in Private Placement to Support Clinica ...

TORONTO, ONTARIO -- (Marketwired) -- 06/30/16 -- Abba Medix Group Inc. ("Abba" or the "Company") (CSE: ABA) is pleased to announce that it has executed an engagement agreement with Mackie Research Capital Corporation ("Mack ...

Abba Medix Group to Acquire Marijuana for Trauma Inc. and the Longevity Project ...

TORONTO, ONTARIO -- (Marketwired) -- 06/30/16 -- Abba Medix Group Inc. ("Abba" or the "Company") (CSE: ABA) is pleased to announce that it has executed a definitive agreement to acquire Marijuana For Trauma Inc. ("MFT" ...

Alle Meldungen von Abba Medix Group Inc.